Update shared on 05 Nov 2025
Fair value Increased 14%Analysts have raised their price target for National Atomic Company Kazatomprom JSC from $43.78 to $49.86, citing incremental adjustments in long-term valuation metrics.
What's in the News
- National Atomic Company Kazatomprom JSC has scheduled a Special/Extraordinary Shareholders Meeting for December 19, 2025 (Key Developments).
- The company updated its production guidance for 2025, maintaining its expected production volume on both 100 percent and attributable bases, as well as group sales volume, with no changes from previous estimates (Key Developments).
- Kazatomprom raised its earnings guidance for 2025 and now projects consolidated revenue between KZT 1,750 billion and KZT 1,850 billion, up from the previous range (Key Developments).
- For the six months ended June 30, 2025, the company reported a year-over-year increase in production volume for U3O8 on both 100 percent and attributable bases (Key Developments).
Valuation Changes
- Consensus Analyst Price Target has increased from $43.78 to $49.86, reflecting a moderate upward revision.
- Discount Rate remains unchanged at 7.99%.
- Revenue Growth estimate is steady at approximately 11.62% year over year.
- Net Profit Margin is maintained at roughly 33.20%.
- Future P/E ratio has risen slightly, moving from 9.41x to 10.43x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.